Skip to main content

and
  1. No Access

    Article

    Physiological and pathological properties of α-synuclein

    α-Synuclein belongs to a small group of natively unfolded proteins that can transiently bind to lipid membranes and acquire a partial α-helical conformation. Under certain pathogenic conditions, α-synuclein ag...

    G. K. Tofaris, M. G. Spillantini in Cellular and Molecular Life Sciences (2007)

  2. No Access

    Article

    A novel leukoencephalopathy associated with tau deposits primarily in white matter glia

    A 79-year-old woman had a 10-year history of dementia, initially presenting as non-fluent aphasia. Magnetic resonance imaging showed frontal atrophy (left greater than right) and hyperintense foci within white...

    J. M. Powers, N. P. Byrne, M. Ito, M. Takao, D. Yankopoulou in Acta Neuropathologica (2003)

  3. No Access

    Article

    Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

    M. G. Spillantini, J.C. Van Swieten, M. Goedert in Neurogenetics (2000)

  4. No Access

    Article

    Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein

    Coding region and intronic mutations in the tau gene cause frontotemporal dementia and parkinsonism linked to chromosome 17. Some of these mutations lead to an overproduction of tau isoforms with four microtu...

    A. Probst, J. Götz, K. H. Wiederhold, M. Tolnay, C. Mistl in Acta Neuropathologica (2000)

  5. No Access

    Chapter and Conference Paper

    Tauopathies and α-Synucleinopathies

    Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases of the human brain. They are characterized by the presence of ordered filamentous assemblies that gradually develop in...

    M. Goedert, M. G. Spillantini in Fatal Attractions: Protein Aggregates in N… (2000)

  6. No Access

    Article

    Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia

    Microtubule-associated protein tau forms neurofibrillary lesions in Alzheimer’s disease and several other neurodegenerative disorders, such as Niemann-Pick disease type C, subacute sclerosing panencephalitis,...

    M. G. Spillantini, M. Tolnay, S. Love, M. Goedert in Acta Neuropathologica (1999)

  7. No Access

    Article

    Tau gene mutation in familial progressive subcortical gliosis

    Familial forms of frontotemporal dementias are associated with mutations in the tau gene. A kindred affected by progressive subcortical gliosis (PSG), a rare form of presenile dementia, has genetic linkage to chr...

    M. Goedert, M.G. Spillantini, R.A. Crowther, S.G. Chen, P. Parchi in Nature Medicine (1999)

  8. Article

    Lewy body diseases and multiple system atrophy as α-synucleinopathies

    M Goedert, M G Spillantini in Molecular Psychiatry (1998)

  9. No Access

    Article

    Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons

    Argyrophilic grains (ArG) and coiled bodies of argyrophilic grain disease (AgD) and the neurofibrillary lesions of Alzheimer’s disease (AD) share similar antigenic determinants, among them hyperphosphorylated...

    M. Tolnay, M. G. Spillantini, M. Goedert, J. Ulrich, D. Langui in Acta Neuropathologica (1997)

  10. No Access

    Article

    Pick’s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment

    Pick bodies and ballooned cells of Pick’s disease and the neurofibrillary lesions of Alzheimer’s disease are characterized by the presence of hyperphosphorylated microtubule-associated protein tau. Little is ...

    A. Probst, M. Tolnay, D. Langui, M. Goedert, M. G. Spillantini in Acta Neuropathologica (1996)

  11. No Access

    Article

    Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

    THE paired helical filament (PHF) is the major component of the neurofibrillary deposits that form a defining neuropathological characteristic of Alzheimer's disease (reviewed in refs 1,2). PHFs are composed ...

    M. Goedert, R. Jakes, M. G. Spillantini, M. Hasegawa, M. J. Smith, R. A. Crowther in Nature (1996)

  12. No Access

    Article

    Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles

    Alzheimer’s disease (AD) is characterised neuropathologically by the presence of abundant extracellular β-amyloid deposits and intracellular neurofibrillary lesions consisting of neurofibrillary tangles, neur...

    M. G. Spillantini, R. A. Crowther, M. Goedert in Acta Neuropathologica (1996)

  13. No Access

    Article

    Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?

    In recent years the role of the peripheral nervous system has been focused on the pathogenesis of rheumatoid arthritis (RA). In particular, substance P (SP), released by the sensory terminals, has been demonst...

    M. Matucci-Cerinic, A. Lombardi, G. Leoncini, A. Pignone in Rheumatology International (1993)

  14. No Access

    Article

    Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system

    ALTHOUGH most proto-oncogenes such as c-myc are involved in cell proliferation, being expressed in a wide range of tissues as well as in progenitors of transformed cells1, others may normally function in cellular...

    J. M. Greenberg, T. Boehm, M. V. Sofroniew, R. J. Keynes, S. C. Barton in Nature (1990)

  15. No Access

    Article

    Molecular neuropathology of Alzheimer's disease:In situ hybridization studies

    1. Abundant senile plaques and neurofibrillary tangles in certain brain regions constitute the major neuropathol...

    M. Goedert, M. G. Spillantini in Cellular and Molecular Neurobiology (1990)

  16. No Access

    Article

    Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas

    The present study was designed to evaluate the simultaneous presence of epinephrine (E), norepinephrine (NE), met-enkephalin (ME)-, somatostatin (SRIF)- and substance P (SP)- like immunoreactivities (LI) in ex...

    E. Baldi, M. L. De Feo, P. Geppetti, V. Carlà in Journal of Endocrinological Investigation (1988)

  17. No Access

    Chapter and Conference Paper

    HPLC and Immunohistochemical Characterization of Substance P-Like Immunoreactivity in a Human Pheochromocytoma

    A case of human adrenal pheochromocytoma, containing elevated concentration of substance P-like immunoreactivity (SP-LI) (217 pmol/g) is described. In the peripheral plasma, however, SP-LI was (8.2 pmol/l) sim...

    M. G. Spillantini, E. Baldi, S. Frilli, S. Marabini in Substance P and Neurokinins (1987)

  18. No Access

    Chapter and Conference Paper

    Substance P Empty Neuron: A Conceptualization of Organic and Functional Deafferentation Syndromes

    When the pain transmission in sensitive nerves is impaired or interrupted by a partial or total organic deafferentation (DFT) the following main events occur: a) lowering of SP content into the ipsimetameric d...

    F. Sicuteri, M. Nicolodi, M. G. Spillantini in Substance P and Neurokinins (1987)

  19. No Access

    Chapter and Conference Paper

    Substance P- and Somatostatin-Like Immunoreactivity in Maternal and in Umbilical Cord Plasma and in Amniotic Fluid

    Substance P containing neurons are present in the female reproductive organs. It has been reported that substance Plike- immunoreactivity (SP-LI) is decreased during pregnancy in maternal plasma as well as in ...

    M. Di Tommaso, G. C. Di Renzo, E. Cosmi, D. Renzi in Substance P and Neurokinins (1987)